BFG
PFE icon

Bleakley Financial Group’s Pfizer PFE Stock Holding History

Bleakley Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.72M Buy
237,694
+64,107
+37% +$1.68M 0.07% 220
2026
Q1 		$4.87M Buy
173,587
+25,800
+17% +$687K 0.08% 221
2025
Q4 		$3.68M Buy
147,787
+24,631
+20% +$621K 0.06% 235
2025
Q3 		$3.14M Buy
123,156
+14,570
+13% +$360K 0.07% 220
2025
Q2 		$2.63M Buy
108,586
+6,259
+6% +$146K 0.07% 243
2025
Q1 		$2.59M Buy
102,327
+18,268
+22% +$478K 0.08% 207
2024
Q4 		$2.23M Sell
84,059
-25,369
-23% -$688K 0.07% 235
2024
Q3 		$3.17M Buy
109,428
+2,914
+3% +$85K 0.1% 179
2024
Q2 		$2.98M Sell
106,514
-11,251
-10% -$310K 0.09% 211
2024
Q1 		$3.27M Sell
117,765
-14,008
-11% -$389K 0.09% 202
2023
Q4 		$3.79M Sell
131,773
-24,807
-16% -$750K 0.12% 163
2023
Q3 		$5.19M Sell
156,580
-13,969
-8% -$494K 0.18% 110
2023
Q2 		$6.26M Buy
170,549
+7,607
+5% +$296K 0.2% 95
2023
Q1 		$6.65M Sell
162,942
-8,519
-5% -$368K 0.22% 87
2022
Q4 		$8.79M Buy
+171,461
New +$8.22M 0.31% 63

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bleakley Financial Group's PFE Position: Q2 2026 in Review

Bleakley Financial Group increased its Pfizer (PFE) stake by 37% in Q2 2026, buying an estimated $1.68M and bringing the position to 237,694 shares worth $5.72M. The position accounts for 0.07% of the portfolio, ranked #220.

Bleakley Financial Group first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.79M in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bleakley Financial Group held 237,694 shares of Pfizer worth $5.72M as of Q2 2026.
  • Bleakley Financial Group bought 64,107 Pfizer shares in Q2 2026, an estimated $1.68M.
  • Pfizer made up 0.07% of Bleakley Financial Group's portfolio in Q2 2026, its #220 holding.
  • Bleakley Financial Group first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Bleakley Financial Group's Pfizer position peaked at $8.79M in Q4 2022.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.